Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets
MUMBAI, India & NAPLES, Fla., June 26, 2026 Lupin Limited announced that it has received tentative approval from the...
Generic Drugs
Advertisement
Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
Apotex Gains Canada Approval for Generic Ozempic
Toronto, Canada | May 1, 2026 Apotex has received Health Canada approval for Apo-Semaglutide Injection™, a generic equivalent of...
Apotex Secures FDA Approval for Generic Infuvite Injection
WESTON, FLORIDA, USA, April 14, 2026 Apotex Corp., in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma...
ANI Pharma Launches Carbamazepine ER Capsules in US
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
Advertisements
DifGen, Apotex Win FDA Approval for Nintedanib Capsules
MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...
Lupin Gains US FDA Nod for Dapagliflozin Tablets
MUMBAI, India and NAPLES, Fla., April 7, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
Lupin Gets FDA Nod for Pitolisant Tablets
MUMBAI, INDIA & NAPLES, USA | March 25, 2026 Lupin Limited, a global pharmaceutical leader, has received tentative approval...
Lupin Launches Topiramate ER Capsules in United States
MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 — Global pharmaceutical company Lupin Limited announced the U.S. launch of...
Advertisement
